Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Insider Filings - WIERENGA WENDALL
Last Updated 
31-Mar-14
Enter symbol:
symbol lookup

 

EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search

WIERENGA WENDALL: Declared Holdings
Company/RelationshipReportedShares  Ownership
Concert Pharmaceuticals, Inc.
Director
NasdaqGM:CNCE
(historical quotes, profile, other insiders)
13-Mar-1412,389  Direct
ONYX Pharmaceuticals, Inc.
Director
NasdaqGS:ONXX
(historical quotes, SEC, other insiders)
1-Oct-130  Direct
Santarus, Inc.
Officer
NasdaqGS:SNTS
(historical quotes, other insiders)
2-Jan-140  Direct
XenoPort, Inc.
Director
NasdaqGS:XNPT
(historical quotes, profile, other insiders)
16-May-138,998  Direct

Insider & restricted shareholder transactions reported over the last two years
DateSharesStockTransaction
13-Mar-14 12,389CNCE Statement of Ownership
2-Jan-14 5,028SNTS Disposition (Non Open Market) at $32 per share.
(Value of $160,896)
1-Oct-13 11,180ONXX Disposition (Non Open Market) at $125 per share.
(Value of $1,397,500)
16-May-13 5,000XNPT Option Exercise at $0 per share.
28-Mar-13 2,100ONXX Acquisition (Non Open Market) at $0 per share.
1-Feb-13 250ONXX Automatic Sale at $77.71 per share.
(Proceeds of $19,427)
1-Nov-12 250ONXX Automatic Sale at $77.21 per share.
(Proceeds of $19,302)
24-Aug-12 5,000ONXX Sale at $74.09 per share.
(Proceeds of $370,450)
24-Aug-12 5,000ONXX Option Exercise at $27.14 per share.
(Cost of $135,700)
1-Aug-12 250ONXX Automatic Sale at $74.76 per share.
(Proceeds of $18,690)
25-Jul-12 1,500ONXX Acquisition (Non Open Market) at $0 per share.
1-May-12 250ONXX Automatic Sale at $45.47 per share.
(Proceeds of $11,367)


EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Data and information are provided by EDGAR Online, Inc. for informational purposes only and not intended for trading purposes. Yahoo!, EDGAR Online, Inc. shall have no liability for the accuracy of the information furnished or for delays, omissions or opinions expressed therein. You may not use the information for any illegal purpose or furnish the information to any person, firm, or branch office for commercial re-use or re-sale.

Questions or Comments?